Cookie Settings
This website uses cookies to improve site functionality and provide you with a better browsing experience. Detailed information on the use of cookies on this website is provided in our Terms & Conditions and in our Cookie Policy. By accepting you consent to the use of all of these cookies.
Click ‘Edit Settings’ to decline these cookies or to make more detailed choices.
Edit cookies
When you visit a website, it may store or retrieve information on your browser, mostly in the form of cookies. The information does not usually directly identify you, but it can give you a more personalised experience. Because we respect your right to privacy, you can choose not to allow some types of cookies.
Click on the different category headings to find out more and to change the default settings. Blocking some types of cookies may impact your experience of the website and the services we can offer. Read our Privacy and Cookie Policy.
Manage Consent Preferences
These cookies are essential so that you can move around the website and use its features. Without these cookies, the services that ask for cannot be provided. These cookies are on by default but can be turned off in your browser settings.
These cookies allow us to count visits and traffic sources so that we can measure and improve the performance of our website. All of the information these cookies collect is aggregated and is therefore anonymous.
These cookies allow the website to remember the choices you make in order to give you better functionality and personal features.
Get the right experience for you. Please select your location and investor type.

Companies supporting the fight against COVID-19
The COVID-19 pandemic is having a devastating personal and economic impact worldwide and there is an urgent need for governments, companies and individuals to play their part in helping to slow the spread, protect the vulnerable and minimise the human and economic toll.
Download PDF versionAcross our portfolios, there are a number of companies that are helping to play a crucial part, either by providing diagnostic tools, expanding their healthcare services, providing extra hand-washing and hygiene supplies or simply making sure we still have food available on our supermarket shelves.
Below is a selection of the most notable examples:
- DiaSorin – an Italian-listed multinational biotechnology company that has successfully launched a rapid response (60 minutes compared to the current 5-7 hours) COVID-19 diagnostic test and are working on an antibody test, expected soon.
- Fisher & Paykel Healthcare – a New Zealand-listed manufacturer of products and systems for use in respiratory care, including breathing apparatus and masks. The company has ramped up their manufacturing output in order to meet the increasing global demand for their respiratory products that are directly involved in treating patients with COVID-19.
- CSL – an Australian-listed company with dominant market position in blood plasma biotherapies used for treating rare diseases, supporting organ transplants, and developing vaccines and anti-venom serums. The company is working as part of an industry alliance to develop potential plasma-derived therapy for treating COVID-19. They are also donating proprietary technology to the University of Queensland’s pre-clinical development program.
- Dr Lal Pathlabs – an Indian-listed blood testing and diagnostic laboratory chain which has been authorised for testing for COVID-19 in India.
- Philips – a Dutch-listed conglomerate that is increasing the production of certain critical care products and solutions to help diagnose and treat patients, including hospital ventilators, vital sign monitors, diagnostic imaging and medical consumables.
- Unilever – the UK and Dutch-listed consumer goods company is donating €100 million worth of soap, sanitiser, bleach and food to the COVID Action Platform of the World Economic Forum, as well as other product donations and handwashing education programmes at a national and local level. They are also offering€500 million of cash flow relief to support small and medium sized enterprises in their supply chain to help them with financial liquidity, and are extending credit to selected small-scale retail customers whose business rely on Unilever, to help them manage and protect jobs.
Of course there are many more examples of companies helping through their business-as-usual operations. These include Ain Holdings, the Japanese-listed franchisor of pharmacies and operator of drugstores, which provides access to consumer health and food products across Japan; Godrej Consumer, the Indian-listed consumer goods company, which sells health and hygiene supplies and also slashed the prices of their hand sanitisers; through to Neogen, the US-listed maker of food safety diagnostic tests, and animal health and hygiene products, including cleaners and disinfectants, for use in agricultural and food production settings. The EPA (United States Environmental Protection Agency) has approved four of their disinfectants to be used against Covid-19.
We trust these well stewarded companies will remain focused on the long-term and not exploit the obvious opportunity to put short-term profits ahead of patient and society welfare.
Investment terms
View our list of investment terms to help you understand the terminology within this document.
Subscribe to our updates
To get regular updates and content from Stewart Investors, please register here.
Important information
This material is for general information purposes only. It does not constitute investment or financial advice and does not take into account any specific investment objectives, financial situation or needs. This is not an offer to provide asset management services, is not a recommendation or an offer or solicitation to buy, hold or sell any security or to execute any agreement for portfolio management or investment advisory services and this material has not been prepared in connection with any such offer. Before making any investment decision you should conduct your own due diligence and consider your individual investment needs, objectives and financial situation and read the relevant offering documents for details including the risk factors disclosure. Any person who acts upon, or changes their investment position in reliance on, the information contained in these materials does so entirely at their own risk.
We have taken reasonable care to ensure that this material is accurate, current, and complete and fit for its intended purpose and audience as at the date of publication but the information contained in the material may be subject to change thereafter without notice. No assurance is given or liability accepted regarding the accuracy, validity or completeness of this material.
To the extent this material contains any expression of opinion or forward-looking statements, such opinions and statements are based on assumptions, matters and sources believed to be true and reliable at the time of publication only. This material reflects the views of the individual writers only. Those views may change, may not prove to be valid and may not reflect the views of everyone at First Sentier Investors.
Past performance is not indicative of future performance. All investment involves risks and the value of investments and the income from them may go down as well as up and you may not get back your original investment. Actual outcomes or results may differ materially from those discussed. Readers must not place undue reliance on forward-looking statements as there is no certainty that conditions current at the time of publication will continue.
References to specific securities (if any) are included for the purpose of illustration only and should not be construed as a recommendation to buy or sell the same. Any securities referenced may or may not form part of the holdings of First Sentier Investors' portfolios at a certain point in time, and the holdings may change over time.
References to comparative benchmarks or indices (if any) are for illustrative and comparison purposes only, may not be available for direct investment, are unmanaged, assume reinvestment of income, and have limitations when used for comparison or other purposes because they may have volatility, credit, or other material characteristics (such as number and types of securities) that are different from the funds managed by First Sentier Investors.
Selling restrictions
Not all First Sentier Investors products are available in all jurisdictions.
This material is neither directed at nor intended to be accessed by persons resident in, or citizens of any country, or types or categories of individual where to allow such access would be unlawful or where it would require any registration, filing, application for any licence or approval or other steps to be taken by First Sentier Investors in order to comply with local laws or regulatory requirements in such country.
This material is intended for ‘professional clients’ (as defined by the UK Financial Conduct Authority, or under MiFID II), ‘wholesale clients’ (as defined under the Corporations Act 2001 (Cth) or Financial Markets Conduct Act 2013 (New Zealand) and ‘professional’ and ‘institutional’ investors as may be defined in the jurisdiction in which the material is received, including Hong Kong, Singapore, Japan and the United States, and should not be relied upon by or be passed to other persons.
The First Sentier Investors funds referenced in these materials are not registered for sale in the United States and this document is not an offer for sale of funds to US persons (as such term is used in Regulation S promulgated under the 1933 Act). Fund-specific information has been provided to illustrate First Sentier Investors’ expertise in the strategy. Differences between fund-specific constraints or fees and those of a similarly managed mandate would affect performance results.
About First Sentier Investors
References to ‘we’, ‘us’ or ‘our’ are references to First Sentier Investors, a global asset management business which is ultimately owned by Mitsubishi UFJ Financial Group, Inc (MUFG). Our investment team operates under the trading name of Stewart Investors which is part of the First Sentier Investors Group.
This material may not be copied or reproduced in whole or in part, and in any form or by any means circulated without the prior written consent of First Sentier Investors.
We communicate and conduct business through different legal entities in different locations. This material is communicated in:
- Australia and New Zealand by First Sentier Investors (Australia) IM Ltd, authorised and regulated in Australia by the Australian Securities and Investments Commission (AFSL 289017; ABN 89 114 194311)
- the European Economic Area by First Sentier Investors (Ireland) Limited, authorised and regulated in Ireland by the Central Bank of Ireland (CBI ref no. C182306; Registered office: 70 Sir John Rogerson’s Quay, Dublin 2, Ireland; Company no. 629188).
- Hong Kong by First Sentier Investors (Hong Kong) Limited and has not been reviewed by the Securities & Futures Commission in Hong Kong. First Sentier Investors and Stewart Investors are business names of First Sentier Investors (Hong Kong) Limited.
- Singapore by First Sentier Investors (Singapore) (Company no. 196900420D) and this advertisement or material has not been reviewed by the Monetary Authority of Singapore. First Sentier Investors (registration number 53236800B) and Stewart Investors (registration number 53310114W) are business divisions of First Sentier Investors (Singapore).
- Japan by First Sentier Investors (Japan) Limited, authorised and regulated by the Financial Service Agency (Director of Kanto Local Finance Bureau (Registered Financial Institutions) No.2611).
- the United Kingdom by First Sentier Investors (UK) Funds Limited, authorised and regulated by the Financial Conduct Authority (FCA ref no. 143359; Registered office: Finsbury Circus House, 15 Finsbury Circus, London EC2M 7EB; Company no. 2294743).
- the United States by First Sentier Investors (US) LLC, authorised and regulated by the Securities Exchange Commission (RIA 801-93167).
- other jurisdictions, where this document may lawfully be issued, by First Sentier Investors International IM Limited, authorised and regulated in the UK by the Financial Conduct Authority (FCA ref no. 122512; Registered office: 23 St. Andrew Square, Edinburgh, EH2 1BB; Company no. SC079063).
To the extent permitted by law, MUFG and its subsidiaries are not liable for any loss or damage as a result of reliance on any statement or information contained in this document. Neither MUFG nor any of its subsidiaries guarantee the performance of any investment products referred to in this document or the repayment of capital. Any investments referred to are not deposits or other liabilities of MUFG or its subsidiaries, and are subject to investment risk, including loss of income and capital invested.
© First Sentier Investors Group
Copyright © 2023 Stewart Investors.
Material on this website is intended to provide general information only. Such material does not into account your objectives, financial situation or needs. You should consider these matters before acting on the information and consider the relevant Product Disclosure Statement for any product named on this website before making an investment decision. Any opinions expressed in videos are the opinions of the individual participant and are subject to change without notice. Such opinions are not a recommendation to hold, purchase or sell a particular financial product and may not include all of the information required to make such a decision. Before making any such decision you should consult a financial adviser.